NCT04969471 - NATURE (EnVast As an Adjunct PPCI in Subjects Presenting with STEMI) | Biotech Hunter

Enrollment

148

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

September 30, 2026

Conditions

Segment Elevation Myocardial Infarction (STEMI)

Interventions

DEVICE

enVast stent

In addition to conventional treatment, the treating physician will deploy as the first measure to obtain reperfusion, a enVast stent at the occlusion site in order to withdraw the clot.

PROCEDURE

conventional treatment

Treatment strategies may include balloon angioplasty, manual aspiration thrombectomy and/or coronary stenting.

Trial Locations (1)

Unknown

RECRUITING

Istituto Cardiocentro Ticino, Lugano